Information about Anthralin

Generic Name : Anthralin
Up-to-date prescription details regarding Anthralin are provided here.

Pronunciation : AN-thrah-lin

Learn the correct pronunciation of the Anthralin, understand it's uses, recommended dosages, its indications, how to take, when to take, when not to take, side effects, special precautions, warnings and its and its storage instructions.

You will also find a list of the medication's International and Indian brand or trade names, as well as its pricing information. For verification of the information presented on this page or for additional clarifications, it's advisable to consult your doctor.

ICD Code : Y56.9 Therapeutic Classification : Antipsoriatics

Trade Names/Brand Names of Anthralin

India :

Psorisome, Psoriatec.

International :

Dritho-Scalp, Zithronal RR, Drithocreme, Micanol, Psorlin, Anthraforte, Anthranol, Anthrascalp

Why is Anthralin Prescribed? (Indications)

This medication is a topical antimitotic, prescribed for psoriasis. It works by slowing the reproduction of skin cells.

When should Anthralin not be taken? (Contraindications)

Contraindicated in patients with acute psoriatic eruptions or history of hypersensitivity.

What is the dosage of Anthralin?

Adult: Topical- As 0.1% ointment/paste: Apply for a few hr before washing off once daily. Apply to skin or scalp for 20 to 60 minutes once a day, then washed or shampooed off. Apply for a few hours before washing off once daily. In some cases, it is applied at night and allowed to remain on the affected areas overnight, then washed off the next morning or before the next application.

How should Anthralin be taken?

It is available as creams, ointment or pastes in 0.1 to 2% strengths to apply topically as directed by your physician.

What are the warnings and precautions for Anthralin?

• Caution should be exercised in patients with history of inflamed psoriatic eruptions, folliculitis, other skin problems, kidney disease, any allergy, who are taking other medications, children, during pregnancy and breastfeeding.

• An interval of at least one week should be allowed between the discontinuance of usage of steroids and the commencement of Dritho-Scalp therapy to avoid rebound phenomenon.

• For external use only; avoid contact with the eyes, nose, and mouth.

• Do not apply this medicine to blistered, raw, or oozing areas of the skin or scalp.

• Avoid use on face, skin flexures, inner thighs, upper arms and genitals.

• Wash your hands thoroughly after applying this medication.

• It may be harmful if swallowed.